WithdrawnPhase 4

Statin Therapy In Patients With Vasospastic Angina

Stopped: Funding issue

South Korea0Started 2017-07

Plain-language summary

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 19 and more * Vasospastic angina * LDL less than 160mg/dl * Written consent Exclusion Criteria: * Coronary artery stenosis more than 50% or ischemic coronary disease * History of percutaneous coronary intervention * Cerebrovascular diseases or peripheral * Dyslipidemia required statin therapy * Heart failure, arrhythmogenic right ventricular dysplasia, hypertrophic cardiomyopathy, akinesia or aneurysm on left ventricular wall, anomaly of coronary artery * NYHA III and IV * Arrhythmia * Primary cardiac electrical diseases * Cardiac pacemaker or implantable defibrillator * Pregnancy or breast feeding * Life expectancy less than 2 years

What they're measuring

The Composite Event of all-cause death, myocardial infarction, angina-related hospitalization

Timeframe: 3 years

Trial details

NCT IDNCT02790528

SponsorSeung-Jung Park

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06

View on ClinicalTrials.gov More Angina Pectoris, Variant trials